Status:
COMPLETED
Effect of Garlic Extracts on Changes in Cerebral Blood Flow
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Healthy
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the safety and efficacy of Garlic extracts for improving of cerebral blood flow.
Eligibility Criteria
Inclusion
- Healthy adults 19 years of age or older as of the screening date
- Those with no history of treatment for hypertension within the last 3 months
- A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing and fully understanding the detailed explanation of this study
Exclusion
- Those with systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 100 mmHg or higher
- Those who have had a stroke, myocardial infarction, percutaneous coronary angioplasty or surgery for coronary angioplasty within the past 6 months
- Persons with acute and severe cardiovascular diseases such as heart failure, myocardial infarction, and stroke
- Those with acute/chronic inflammation such as cancer, rheumatic disease, autoimmune disease, gastrointestinal disease, etc.
- Those who have a history of gastrointestinal diseases (eg Crohn's disease) or gastrointestinal surgery (except simple appendicectomy or hernia surgery) that may affect the absorption of the product for human application testing
- Persons who have taken prohibited concomitant drugs within the last 3 months
- Persons with a history of clinically significant hypersensitivity reactions to drugs and health functional foods
- Those who have received antipsychotic drug treatment within 2 months before the screening test
- Persons with a history of drug or alcohol abuse
- Pregnant or lactating women
- When women of childbearing potential of childbearing potential do not accept the implementation of appropriate contraceptive methods (except for women who have undergone sterilization)
- Subjects who have participated in health functional food related research or clinical trials within the last 3 months
- In case the principal investigator judges that it is not appropriate to participate in this study
Key Trial Info
Start Date :
October 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05349253
Start Date
October 27 2020
End Date
March 31 2021
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan national university Yangsan Hospital
Gyeongsang, Yangsan, South Korea, 50610